These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 16897634

  • 1. Vitamin E intake and quality of life in amyotrophic lateral sclerosis patients: a follow-up case series study.
    Galbussera A, Tremolizzo L, Brighina L, Testa D, Lovati R, Ferrarese C, Cavaletti G, Filippini G.
    Neurol Sci; 2006 Jul; 27(3):190-3. PubMed ID: 16897634
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. High dose vitamin E therapy in amyotrophic lateral sclerosis as add-on therapy to riluzole: results of a placebo-controlled double-blind study.
    Graf M, Ecker D, Horowski R, Kramer B, Riederer P, Gerlach M, Hager C, Ludolph AC, Becker G, Osterhage J, Jost WH, Schrank B, Stein C, Kostopulos P, Lubik S, Wekwerth K, Dengler R, Troeger M, Wuerz A, Hoge A, Schrader C, Schimke N, Krampfl K, Petri S, Zierz S, Eger K, Neudecker S, Traufeller K, Sievert M, Neundörfer B, Hecht M, German vitamin E/ALS Study Group.
    J Neural Transm (Vienna); 2005 May; 112(5):649-60. PubMed ID: 15517433
    [Abstract] [Full Text] [Related]

  • 4. Vitamin E intake and risk of amyotrophic lateral sclerosis.
    Ascherio A, Weisskopf MG, O'reilly EJ, Jacobs EJ, McCullough ML, Calle EE, Cudkowicz M, Thun MJ.
    Ann Neurol; 2005 Jan; 57(1):104-10. PubMed ID: 15529299
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug therapy for amyotrophic lateral sclerosis: Where are we now?
    Carter GT, Krivickas LS, Weydt P, Weiss MD, Miller RG.
    IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618
    [Abstract] [Full Text] [Related]

  • 7. Three soccer playing friends with simultaneous amyotrophic lateral sclerosis.
    Wicks P, Ganesalingham J, Collin C, Prevett M, Leigh NP, Al-Chalabi A.
    Amyotroph Lateral Scler; 2007 Jun; 8(3):177-9. PubMed ID: 17538780
    [Abstract] [Full Text] [Related]

  • 8. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Zis V, Sfagos C, Vassilopoulos D.
    Clin Neurol Neurosurg; 2008 Mar; 110(3):222-6. PubMed ID: 18055102
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [What are the etiological medical therapies in amyotrophic lateral sclerosis?].
    Dib M.
    Rev Neurol (Paris); 2006 Jun; 162 Spec No 2():4S215-4S219. PubMed ID: 17128114
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
    Yanagisawa N, Shindo M.
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
    [Abstract] [Full Text] [Related]

  • 13. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I, Camu W, Hillaire-Buys D.
    Therapie; 2000 Dec; 55(2):303-12. PubMed ID: 10967703
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. What has changed with riluzole?
    Meininger V, Lacomblez L, Salachas F.
    J Neurol; 2000 Dec; 247():19-22. PubMed ID: 11200701
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Limitations of inferences from observational databases in amyotrophic lateral sclerosis: all that glitters is not gold.
    Armon C, Guiloff RJ, Bedlack R.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Sep; 3(3):109-12. PubMed ID: 12495570
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: examination of symptoms and signs at disease onset and during follow-up.
    Tartaglia MC, Rowe A, Findlater K, Orange JB, Grace G, Strong MJ.
    Arch Neurol; 2007 Feb; 64(2):232-6. PubMed ID: 17296839
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.